Harmony Biosciences Holdings
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), andEPX-200 (lorcaserin), among others.
公司地址 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA, USA, 19462
電話號碼 +1 484 539-9800
傳真號碼 --
公司網頁 https://www.harmonybiosciences.com
員工數量 293
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Jeffrey M. Dayno, M.D. Chief Executive Officer, President and Director 美元 715.00K 24/02/2026
Mr. Sandip S. Kapadia, C.P.A.,M.B.A. Chief Financial Officer, Principal Accounting Officer and Chief Administrative Officer 美元 507.61K 24/02/2026
Mr. Kumar Budur Chief Medical Officer 美元 555.15K 04/04/2025
Mr. Andrew Serafin Chief Strategy Officer 美元 420.29K 04/04/2025
Mr. Adam Zaeske Executive Vice president and Chief Commercial officer -- 24/03/2025
 
董事會成員
董事會 職務 更新日期
Mr. Jeffrey S. Aronin Chairman of the Board 24/02/2026
Mr. R. Mark Graf Independent Director 24/02/2026
Mr. Gary L. Sender Independent Director 24/02/2026
Mr. Antonio J. Gracias Independent Director 24/02/2026
Dr. Andreas Wicki, PhD Independent Director 24/02/2026
Dr. Jeffrey M. Dayno, M.D. Chief Executive Officer, President and Director 24/02/2026
Ms. Linda M. Szyper Independent Director 24/02/2026
Mr. Juan A. Sabater Independent Director 24/02/2026
Mr. Ron Philip Independent Director 24/02/2026
Mr. Peter Anastasiou Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:05)
代號 名稱 佔比% ▼ 持有日期
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0001%27/02/2026
HDGProShares Hedge Replication0.0001%27/02/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%27/02/2026
AVTMAvantis Total Equity Markets ETF0.00003%28/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
BOUTInnovator IBD® Breakout Opps ETF<0.000001%06/08/2025
CLSEConvergence Long/Short Equity ETF<0.000001%03/02/2026
DEEPAcquirers Small and Micro Deep Value ETF<0.000001%22/12/2025
EBITHarbor AlphaEdge Small Cap Earners ETF<0.000001%01/08/2025
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
FADFirst Trust Multi Cap Gr AlphaDEX® ETF<0.000001%07/10/2025
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%25/11/2025
FTLSFirst Trust Long/Short Equity ETF<0.000001%01/09/2025
FYCFirst Trust Small Cap Gr AlphaDEX® ETF<0.000001%07/10/2025
HKNDHumankind US Stock ETF<0.000001%24/11/2025
HLGEHartford Longevity Economy ETF<0.000001%11/06/2025
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%28/02/2026
ISCGiShares Morningstar Small-Cap Growth ETF<0.000001%28/02/2026
LITLSimplify Piper Sandler USSm-CpPLUSIncETF<0.000001%31/12/2025
SEISSEI Select Small Cap ETF<0.000001%15/08/2025
  1    2    3    4    5   6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.